Four Cooley Lawyers Recognized Among Top Professionals in San Diego

San Diego – November 18, 2022 – Four Cooley lawyers have been named on the San Diego Business Journal’s SD 500 list, which highlights the most influential people in San Diego who are making a significant impact on the business community and the community at large.

The publication recognized Michael Attanasio, partner in charge of Cooley’s San Diego office and chair of the firm’s global litigation department, who was noted for his high-profile trial work.

Additionally, Barbara Borden, co-chair of Cooley’s M&A practice, was noted for representing San Diego’s Turning Point Therapeutics in its $4.1 billion sale to Bristol Myers Squibb, as well as Horizon Therapeutics in its $3 billion acquisition of Viela Bio.

Senior counsel Wainwright Fishburn was noted for his past service as global chair of the firm’s digital health group, his current position as chair of the Critical Path Institute, and his role as a founding partner of the firm’s San Diego office.

Lastly, partner Steven Strauss was described as a “first chair trial lawyer” and noted for “decades of successful trial verdicts and settlements in excess of $10 billion,” including his victory representing Chicago Title in ongoing litigation arising from a $400 million Ponzi scheme.

These recognitions follow on the heels of Cooley’s San Diego office’s relocation to a state-of-the-art space in the heart of the city’s life sciences community – a move that aligns with the firm’s focus on designing workspaces that deploy next-generation technology to foster collaboration and enhance the overall client experience.

Launched in 1992, the firm’s San Diego office has been a key driver of Cooley’s US and international growth, guiding clients’ businesses through their life cycle while protecting and defending them against bet-the-company litigation. The firm has worked with many of the area’s most innovative and high-growth companies, from formation to going public and beyond.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,500 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of 3,300.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.